Revised: 7 November 2019
Information for Healthcare Professionals
This section provides information useful to healthcare professionals.
Medsafe Advice
| Date | Type | Title |
|---|---|---|
| 29/06/2020 | Committees | Comments on agenda items for the 64th meeting of the Medicines Classification Committee to be held on 9 July 2020 |
| 24/06/2020 | Committees | Agenda for the 64th Medicines Classification Committee meeting The date of the meeting has been changed to 9 July 2020 |
| 9/06/2020 | Alert Communication | Important updates to clozapine data sheets and monitoring during covid-19 pandemic |
| 4/06/2020 | Publications | Prescriber Update 41(2) - June 2020 |
| 28/05/2020 | Alert Communication | Miracle Mineral Solution - dangerous and potentially life-threatening side effects |
| 21/05/2020 | Monitoring Communication | Update - Possible risk of vasculitis with dabigatran (Pradaxa) |
| 21/05/2020 | Monitoring Communication |  Potential interaction between fluoxetine and
levothyroxine |
If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.
